335 related articles for article (PubMed ID: 20664611)
21. Current status of positron emission tomography radiotracers for serotonin receptors in humans.
Zimmer L; Le Bars D
J Labelled Comp Radiopharm; 2013; 56(3-4):105-13. PubMed ID: 24285316
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and biological evaluation of potential 5-HT(7) receptor PET radiotracers.
Andries J; Lemoine L; Le Bars D; Zimmer L; Billard T
Eur J Med Chem; 2011 Aug; 46(8):3455-61. PubMed ID: 21620533
[TBL] [Abstract][Full Text] [Related]
23. Assessment of serotonin release capacity in the human brain using dexfenfluramine challenge and [18F]altanserin positron emission tomography.
Quednow BB; Treyer V; Hasler F; Dörig N; Wyss MT; Burger C; Rentsch KM; Westera G; Schubiger PA; Buck A; Vollenweider FX
Neuroimage; 2012 Feb; 59(4):3922-32. PubMed ID: 21996132
[TBL] [Abstract][Full Text] [Related]
24. Brain serotonin 5-HT(1A) receptor binding in schizophrenia measured by positron emission tomography and [11C]WAY-100635.
Tauscher J; Kapur S; Verhoeff NP; Hussey DF; Daskalakis ZJ; Tauscher-Wisniewski S; Wilson AA; Houle S; Kasper S; Zipursky RB
Arch Gen Psychiatry; 2002 Jun; 59(6):514-20. PubMed ID: 12044193
[TBL] [Abstract][Full Text] [Related]
25. Monoamine neurocircuitry in depression and strategies for new treatments.
Hamon M; Blier P
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():54-63. PubMed ID: 23602950
[TBL] [Abstract][Full Text] [Related]
26. Positron emission tomography imaging of the serotonin transporter and 5-HT(1A) receptor in alcohol dependence.
Martinez D; Slifstein M; Gil R; Hwang DR; Huang Y; Perez A; Frankle WG; Laruelle M; Krystal J; Abi-Dargham A
Biol Psychiatry; 2009 Jan; 65(2):175-80. PubMed ID: 18962444
[TBL] [Abstract][Full Text] [Related]
27. Structural and functional neuroimaging studies of the suicidal brain.
Desmyter S; van Heeringen C; Audenaert K
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):796-808. PubMed ID: 21216267
[TBL] [Abstract][Full Text] [Related]
28. A positron emission tomography study of 5-hydroxytryptamine-1A receptors in Alzheimer disease.
Lanctôt KL; Hussey DF; Herrmann N; Black SE; Rusjan PM; Wilson AA; Houle S; Kozloff N; Verhoeff NP; Kapur S
Am J Geriatr Psychiatry; 2007 Oct; 15(10):888-98. PubMed ID: 17567932
[TBL] [Abstract][Full Text] [Related]
29. Fluorine-18 labeled diphenyl sulfide derivatives for imaging serotonin transporter (SERT) in the brain.
Zhang Y; Liu F; Xiao H; Yao X; Li G; Choi SR; Ploessl K; Zha Z; Zhu L; Kung HF
Nucl Med Biol; 2018 Nov; 66():1-9. PubMed ID: 30096380
[TBL] [Abstract][Full Text] [Related]
30. Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review.
Laruelle M
J Cereb Blood Flow Metab; 2000 Mar; 20(3):423-51. PubMed ID: 10724107
[TBL] [Abstract][Full Text] [Related]
31. Fenfluramine-induced serotonin release decreases [11C]AZ10419369 binding to 5-HT1B-receptors in the primate brain.
Finnema SJ; Varrone A; Hwang TJ; Gulyás B; Pierson ME; Halldin C; Farde L
Synapse; 2010 Jul; 64(7):573-7. PubMed ID: 20222157
[TBL] [Abstract][Full Text] [Related]
32. Serotonergic neurotransmission in the living human brain: a positron emission tomography study using [¹¹C]dasb and [¹¹C]WAY100635 in young healthy men.
Takano H; Ito H; Takahashi H; Arakawa R; Okumura M; Kodaka F; Otsuka T; Kato M; Suhara T
Synapse; 2011 Jul; 65(7):624-33. PubMed ID: 21484882
[TBL] [Abstract][Full Text] [Related]
33. Use of PET and the radioligand [carbonyl-(11)C]WAY-100635 in psychotropic drug development.
Andrée B; Halldin C; Thorberg SO; Sandell J; Farde L
Nucl Med Biol; 2000 Jul; 27(5):515-21. PubMed ID: 10962260
[TBL] [Abstract][Full Text] [Related]
34. Nuclear Neuroimaging in Social Anxiety Disorder: A Review.
Doruyter AG; Dupont P; Stein DJ; Lochner C; Warwick JM
J Nucl Med; 2018 Dec; 59(12):1794-1800. PubMed ID: 30291197
[TBL] [Abstract][Full Text] [Related]
35. Reduced serotonin receptors and transporters in normal aging adults: a meta-analysis of PET and SPECT imaging studies.
Karrer TM; McLaughlin CL; Guaglianone CP; Samanez-Larkin GR
Neurobiol Aging; 2019 Aug; 80():1-10. PubMed ID: 31055162
[TBL] [Abstract][Full Text] [Related]
36. [18F]F15599, a novel 5-HT1A receptor agonist, as a radioligand for PET neuroimaging.
Lemoine L; Verdurand M; Vacher B; Blanc E; Le Bars D; Newman-Tancredi A; Zimmer L
Eur J Nucl Med Mol Imaging; 2010 Mar; 37(3):594-605. PubMed ID: 19789870
[TBL] [Abstract][Full Text] [Related]
37. Vulnerability of positron emission tomography radiotracers to endogenous competition. New insights.
Laruelle M; Huang Y
Q J Nucl Med; 2001 Jun; 45(2):124-38. PubMed ID: 11476162
[TBL] [Abstract][Full Text] [Related]
38. Characterization of in vivo pharmacological properties and sensitivity to endogenous serotonin of [11C] P943: a positron emission tomography study in Papio anubis.
Ridler K; Plisson C; Rabiner EA; Gunn RN; Easwaramoorthy B; Abi-Dargham A; Laruelle M; Slifstein M
Synapse; 2011 Nov; 65(11):1119-27. PubMed ID: 21538549
[TBL] [Abstract][Full Text] [Related]
39. Radiosynthesis and in vivo evaluation of a series of substituted 11C-phenethylamines as 5-HT (2A) agonist PET tracers.
Ettrup A; Hansen M; Santini MA; Paine J; Gillings N; Palner M; Lehel S; Herth MM; Madsen J; Kristensen J; Begtrup M; Knudsen GM
Eur J Nucl Med Mol Imaging; 2011 Apr; 38(4):681-93. PubMed ID: 21174090
[TBL] [Abstract][Full Text] [Related]
40. Sex differences in the serotonin 1A receptor and serotonin transporter binding in the human brain measured by PET.
Jovanovic H; Lundberg J; Karlsson P; Cerin A; Saijo T; Varrone A; Halldin C; Nordström AL
Neuroimage; 2008 Feb; 39(3):1408-19. PubMed ID: 18036835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
